Charles H. Sherwood, President and CEO at Anika Therapeutics, Inc. (ANIK), sold 83,780 shares at $44.32 ($3.7M) on 2014-05-01, disclosed to the SEC on 2014-05-02.
Open-market sale of $3.7M ANIK by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANIK | SELL | 2017-10-18 | $395K | — | Filing → |
| ANIK | SELL | 2017-10-16 | $742K | — | Filing → |
| ANIK | SELL | 2017-07-31 | $6.5M | — | Filing → |